000 01357 a2200397 4500
005 20250514170840.0
264 0 _c20040322
008 200403s 0 0 eng d
022 _a1522-8517
024 7 _a10.1215/S1152851703000395
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVernino, Steven
245 0 0 _aImmunomodulatory treatment trial for paraneoplastic neurological disorders.
_h[electronic resource]
260 _bNeuro-oncology
_cJan 2004
300 _a55-62 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
650 0 4 _aAdjuvants, Immunologic
_xtherapeutic use
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aConfidence Intervals
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aParaneoplastic Syndromes, Nervous System
_xblood
650 0 4 _aProspective Studies
700 1 _aO'Neill, Brian Patrick
700 1 _aMarks, Randolph S
700 1 _aO'Fallon, Judith R
700 1 _aKimmel, David W
773 0 _tNeuro-oncology
_gvol. 6
_gno. 1
_gp. 55-62
856 4 0 _uhttps://doi.org/10.1215/S1152851703000395
_zAvailable from publisher's website
999 _c14492562
_d14492562